Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Newave Pharmaceutical patents Bcl-2 inhibitors

March 12, 2020

Phase III GY004 study does not meet primary endpoint

March 12, 2020

Update on clinical development of opaganib

March 12, 2020

New STAT3 inhibitor inhibits tumor growth and metastasis in preclinical models of colorectal cancer

March 12, 2020

Unexpected mechanism, combination possibilities for CDK4/6 inhibitors

March 12, 2020

Nucana reports preliminary data from phase II study of Acelarin in ovarian cancer

March 11, 2020

Beijing Scitech-Mq Pharmaceuticals identifies VEGFR-2 and CSF-1R inhibitors

March 11, 2020

Beijing Yuezhikangtai Biomedicines presents new tyrosine kinase inhibitors

March 11, 2020

Rudong Ringene Pharmaceuticals divulges FGFR inhibitors

March 11, 2020

Chinese researchers patent JAK inhibitors

March 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...